Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "heart failure" return 16 results.
Ceva partners with Liryc, the global leading institute in heart rhythm disorders >
The objective: to promote One Health platform of excellence dedicated to cardiology, stimulating research and medical innovation at the interface between humans and companion animals.
Ceva builds on its preventative health strategy with opening of a new European reference for the manufacture of autogenous vaccines >
An innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics.
Ceva brings together international experts in human cardiology and veterinary to stimulate innovation >
Cardio Symposium Human - Veterinary 2019 (September 17 - Milan)
One Health put into practice: Veterinary and human cardiologists discuss cardiovascular disease in pets >
Paris, February 2016 - ‘Making tomorrow happen today’ was the theme of the human-veterinary cross-talk symposium organised by Ceva on February 19.
Tildren® receives FDA approval to control clinical signs of Navicular Syndrome >
Tildren® is now available in the US
Ceva Santé Animale awards the “Fondation du Patrimoine” Prize for Animal Agro-Biodiversity >
On February 27, Marc Prikazsky, CEO of global veterinary health company Ceva Santé Animale, will officially present the award during the Paris International Agricultural Show the “Fondation du Patrimo...
Ceva acquires Sogeval >
Sogeval, a subsidiary of Sofiprotéol, joins veterinary firm Ceva Santé Animale with a view to creating one of the world leaders in veterinary pharmacy.
Ceva and Sogeval in exclusive negotiations to create a global leader in animal health >
Ceva and Sogeval (a subsidiary of Sofiprotéol), based in Laval announce the opening of exclusive negotiations to create a future alliance.
2013 reprodAction Scientific Meeting - April 16-17th >
“Management and reproduction of dairy heifers”
Ceva launches CARDALIS® for dogs with heart failure >
A powerful dual treatment in a single tablet